Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Will the CAGR of the Viral And Non-Viral Vector Manufacturing Market Influence Its Overall Growth by 2034?
The viral and non-viral vector manufacturing market has expanded rapidly in recent years. It is projected to rise from $8.67 billion in 2024 to $10.3 billion in 2025, reflecting a CAGR of 18.8%. The historical growth can be linked to the rising prevalence of genetic disorders, advancements in biotechnology, increasing investments in gene therapy research, greater awareness of personalized medicine, and regulatory backing for gene therapy development.
The viral and non-viral vector manufacturing market is projected to experience exponential growth, reaching $22.06 billion by 2029 at a CAGR of 21.0%. This growth will be fueled by increasing demand for gene therapies, broader applications in rare disease treatments, rising investments in biomanufacturing infrastructure, and the growing adoption of precision medicine. Key trends in this market include the development of next-generation viral vectors, increased utilization of CRISPR and Cas9 technology in vector manufacturing, a focus on scalable and cost-effective production methods, a rising preference for non-viral vectors, and advancements in cell and gene therapy manufacturing technologies.
Which Factors Are Enhancing the Growth of the Market?
The growing incidence of genetic disorders is expected to boost the viral and non-viral vector manufacturing markets. Genetic disorders are conditions caused by mutations or changes in the DNA sequence. Viral vectors deliver therapeutic genes to target cells, helping to replace or correct defective genes, while non-viral vectors are often used for ex vivo gene therapy. For example, the International Diabetes Federation reported in June 2022 that the prevalence of diabetes worldwide had risen to 10.5%, with projections showing that nearly 783 million adults are expected to have diabetes by 2045. Consequently, the increasing prevalence of genetic disorders is driving the growth of the viral and non-viral vector manufacturing market.
Explore Comprehensive Insights Into The Global Viral And Non-Viral Vector Manufacturing Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12570&type=smp
Who Are the Leading Companies Pioneering Change in the Viral And Non-Viral Vector Manufacturing Market?
Major companies operating in the viral and non-viral vector manufacturing market include:
• Novartis AG
• Thermo Fisher Scientific Inc.
• Merck KGaA
• FUJIFILM Holdings Corporation
• Regeneron Pharmaceuticals Inc.
What Are the Most Significant Trends Transforming the Viral And Non-Viral Vector Manufacturing Market Today?
The viral and non-viral vector manufacturing market is evolving through technological advancements, with leading companies developing next-generation solutions to sustain their market position. For instance, in August 2022, Merck KGaA, a Germany-based science and technology company, introduced the VirusExpress 293 Adeno-Associated Virus (AAV) Production Platform. As one of the first contract development and manufacturing organizations (CDMOs) and technology innovators to offer a comprehensive viral vector manufacturing package, including AAV, Lentiviral, CTO, and process development, this platform accelerates clinical manufacturing timelines while reducing process development costs.
Secure Your Global Viral And Non-Viral Vector Manufacturing Market Report Now for Fast and Efficient Delivery!
How Are Key Segments Defining the Competitive Landscape of the Viral And Non-Viral Vector Manufacturing Market?
The viral and non-viral vector manufacturing market covered in this report is segmented –
1) By Vector Type: Viral Vector, Non-Viral Vector
2) By Disease: Cancer, Genetic Disease, Infectious Disease, Cardiovascular Disease, Other Diseases
3) By Application: Gene Therapy, Vaccinology, Cell Therapy, Other Applications
Subsegments:
1) By Viral Vector: Adenoviral Vectors, Lentiviral Vectors, AAV (Adeno-Associated Virus) Vectors, Retroviral Vectors, Other Viral Vectors
2) By Non-Viral Vector: Plasmid DNA, Lipid-Based Vectors, Nanoparticles, Electroporation-Based Vectors, Other Non-Viral Vectors
Which Regions Are Leading the Charge in Viral And Non-Viral Vector Manufacturing Market Development?
North America was the largest region in the viral and non-viral vector manufacturing market in 2024. The regions covered in the viral and non-viral vector manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
How Is the Definition of the Viral And Non-Viral Vector Manufacturing Market Impacting Future Growth?
Viral and non-viral vector manufacturing refers to producing viral and non-viral vectors, tools that deliver genetic material into cells. Viral vectors treat human diseases and are used in anticancer and gene therapies. Non-viral vectors are utilized for a variety of gene therapy applications, particularly for the creation of vaccines and the treatment of cancer.
Browse Through More Similar Reports By The Business Research Company:
Viral Vectors And Plasmid DNA Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report
Antivirals Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report
Antiviral Combination Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/antiviral-combination-therapy-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
